We report a case of a young woman who presented with classical symptoms and signs of meningococcaemia, but whose diagnosis was one of cerebral lupus. With early and high dose steroid therapy she made a complete recovery from this acute episode. The occasionally florid nature of some of the immune complex diseases and their ability to activate the same inflammatory mediators necessitates their consideration in the differential diagnosis of sepsis syndrome, especially when no microbiological aetiology can be readily identified.
CASE HISTORY
A single 25-year-old South African born woman presented to our institution with a two-day history of increasing lethargy, abdominal pain, vomiting and diarrhoea, after a vague two-week history of malaise and a dry cough. Her recent menstruation had been heavy and prolonged. A renal biopsy performed three years earlier during investigation of proteinuria had shown minimal change glomerulonephritis. She had declined follow-up, and had been well in the interim. She was on no medications.
On arrival in the Emergency Room she was convulsing. Initial examination by the Intensive Care Unit staff revealed a moderately obese, intubated and sedated young woman. She was febrile (39.4 0c), tachycardic (162/min.) but normotensive (126/56). She had poor peripheral per fusion, and her skin was remarkable for the acral patchy purpuric rash which had become confluent and developed haemorrhagic bullae on the dorsal aspects of the hands and feet (Figures lea) and (b)). Auscultation of her precordium revealed a short mid-systolic murmur; her chest was clear. Neck rigidity was not assessable because of prior administration of neuromuscular blockade. Her pupils were equal and reactive; the fundi demonstrated no papilloedema. Initial investigations are summarized in Table 1 . Blood, urine, sputum and high vaginal swabs were cultured and auto immune serology and quantitative serum electrophoresis requested. In the Emergency Department she had received cefotaxime 2.0g. Initial management consisted of fluid resuscitation to improve peripheral per fusion, weaning sedation to assess neurological status, commencing intravenous imipenem (LOg six hourly) for a provisional diagnosis of sepsis and the use of a low-dose dopamine infusion in an attempt to improve urine output. When initial microscopy of all appropriate specimens revealed no pathogen, a systemic vasculitic condition such as cerebral lupus was considered the most likely diagnosis. The original renal biopsy was reviewed; electron microscopy had revealed focal immune complex deposition consistent with systemic lupus erythematosus.
High-dose steroid therapy was commenced with intravenous methylprednisolone l.Og twice daily. Subsequently the anti-DNA level was estimated at 1:80, with reduction in C 3 , C 4 and C Reactive Protein levels. A creatinine kinase level at admission was 1250 units (normal < 200). Anticardiolipin antibodies and lupus anticoagulant assay were both negative. Porphyrin assay demonstrated mildly elevated urinary coproporphyrin (64 nmol/mmol creatinine) but normal faecal porphyrins (60 nmol/g), and thus were not consistent with either acute porphyria or variagate porphyria. An echocardiogram excluded a valvular abnormality.
For two days some myoclonic activity was observed despite high-dose clonazepam and thiopentone by infusion. An EEG revealed diffuse bilateral slow wave activity consistent with a generalized metabolic, toxic or vasculitic abnormality. Her depressed level of consciousness and bilateral basal pneumonic collapse required mechanical ventilation for twelve days at which time a tracheostomy was performed. At this point the patient had slowly recovered neurologically and was able to obey commands. The patient subsequently weaned rapidly from ventilatory support and was transferred to the ward three days later. Her serum Anaesthesia and Intensive Care, Vol. 23, No. 3, June, 1995 creatinine level returned to within normal limits over the first four days of the therapy. She was discharged home well, on glucocorticoid therapy.
DISCUSSION
When patients present with fever, altered mental state, seizures, and purpura fulminans, the likely diagnosis is meningococcal sepsis, with other microbial aetiologies such as streptococcal infection to be considered. Although haemorrhagic bullae may occur in meningococcaemia, their presence is also consistent with a vasculitic lesion. In this patient however the likely diagnosis could not be confirmed by microbiological investigations and the history three years earlier of a renal biopsy for proteinuria led to the correct diagnosis and therapy.
The so-called sepsis syndrome' may not be due to the presence of microorganisms: those diseases that result in activation of inflammatory mediators, such as the immune complex diseases, and the vasculitides can result in an identical clinical picture, including shock, altered mental state, disseminated intravascular coagulopathy, renal impairment, left shift of the granulocytic component of the blood film and myocardial depression.
Systemic lupus erythematosus (SLE) is a disease characterized by the presence of pathogenic auto antibodies and deposition of immune complexes causing end-organ damage. Its aetiology is unknown, its presentation protean, but most commonly involves joints, skin and kidneys'. Mild neuropsychiatric disturbance is common but florid manifestations such as coma and seizure activity are not. Cerebral lupus describes a form of lupus where the predominant findings are severe neurological perturbations. The cause may be small cerebral vessel vasculitis, particularly involving immune complex deposition within the choroid plexus' or a concomitant thrombotic thrombocytopaenic purpura (TTP) syndrome 2 • Most authors ascribe the neurological changes to cerebral vasculitis but one post mortem study refuted the common occurrence of vasculitis' and another has demonstrated the high rate of association between cerebral lupus and TTP'.
Global cerebral blood flow (CBF) as measured by xenon-I33 method is significantly lower than normal during attacks of cerebral lupus 6 • As well, a focal decrease in cerebral blood flow within affected areas of the brain has been demonstrated by single photon emision computed tomography (SPECT) 7 in patients with lupus with or without clinical signs. Magnetic resonance imaging revealed focal lesions after 53070 of acute neuropsychiatric events in patients with lupus, and in five out of six with seizures' and thus may be more specific than SPECT and the investigation of choice. In our patient MRI was not available at the time. The benefit of such a confirmatory investigation must be weighed against the risk of transporting such a critically ill person. There has been a recent review of the use of CT scanning in the critically ill patient with SLP. Of note, most of the patients reviewed did not manifest cerebral lupus and none had such florid peripheral vasculitic signs, although all were critically ill.
There are no studies proving the benefit of steroids in cerebral lupus. However its empirical use in this case and others lO has resulted in clinical improvement. Plasmapheresis has been used in the treatment of severe exacerbations of cerebral lupus l 1.l2.
Cerebral lupus is a potentially fatal condition. In a longterm follow-up of 56 patients with biopsy proven lupus nephritis, five (11.2070) died, in two the cause was cerebral lupus, in two a cerebrovascular accident and in one sepsis l '.
In summary, immune mediated illnesses may mimic sepsis. The diagnosis can be made based on careful history, examination and relevant investigations. When patients present with symptoms and signs of sepsis but no organism is identifiable, other causes of inflammatory mediator activation should be sought and appropriate therapy immediately initiated.
